Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca - Wikidata - awgldk - TriplyDB

Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca

Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca

http://www.wikidata.org/entity/Q34110644

about

Immunomodulation on the ocular surface: a review Dendritic cell-derived thrombospondin-1 is critical for the generation of the ocular surface Th17 response to desiccating stress.Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome The core mechanism of dry eye disease is inflammation.TGFβ signaling inhibits goblet cell differentiation via SPDEF in conjunctival epithelium.Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model.Sjögren syndrome: what and where are we looking for?Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction.T helper cytokines in dry eye disease CD8⁺ cells regulate the T helper-17 response in an experimental murine model of Sjögren syndrome.Ocular surface disease and dacryoadenitis in aging C57BL/6 mice.The T cell in Sjogren's syndrome: force majeure, not spectateur.Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca.TFOS DEWS II Tear Film Report.Mucosal immune tolerance at the ocular surface in health and disease.Intense pulsed light for evaporative dry eye disease.Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome.Reduced intraepithelial corneal nerve density and sensitivity accompany desiccating stress and aging in C57BL/6 mice.

P2860

Q26740643-CACA8A4A-C5A2-426E-A357-880EFB633CFF Q33732669-160EC573-7554-477C-A6A6-54E0E1BE88FE Q33838722-01840528-CC80-4A51-A81C-77A5549139EE Q34510429-7287D95A-B9C6-4E3F-9E06-1477C855AB81 Q34999356-612E3814-8E17-4575-A195-668F32B395C3 Q35773063-DAFA28BD-9839-4AEA-9796-559DE20AC1E6 Q36050556-F0DF4E46-761B-49DF-8B35-C7A7C829CD63 Q36243207-4594E1FE-D903-423A-8AE5-F9300B86D1E0 Q36395133-D31A015E-5CDE-4E9A-BB9C-81D4459D4BCC Q37374838-6E3BB374-120E-4242-BFED-0337F9DDF3D3 Q37407580-EEF1A357-DEFB-46FA-8C5C-729D7F6F63F9 Q37605983-A912A6ED-1855-45C8-8606-9720B99647BB Q38019664-4683403B-A64D-42DF-AA46-483FE605CD13 Q38176265-4AF57BE4-068E-42C8-9049-87115FD6A7CB Q38652990-753B98A2-148C-41DC-8681-4979157343C4 Q39097223-F1F97D50-D6E3-41CA-861D-E95C0921CCA5 Q41015875-8B559856-73F3-411A-88EE-79CFAEBF78AB Q47203561-47BDEEB1-A925-4A25-B20F-558E2CE1B3D9 Q50178476-4D6EFE25-FCC4-47AA-AADA-23AE5213156E

P2860

Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca

http://www.wikidata.org/entity/Q34110644

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@ast

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@en

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@nl

type

label

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@ast

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@en

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@nl

prefLabel

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@ast

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@en

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@nl

P1433

Q34110644-CF79454B-F21D-491B-8BD0-88EE61DEDCD3

P1476

Q34110644-BC063507-EEF7-41A6-AA77-2A34355E3947

P2093

Q34110644-13983870-CC35-42CA-81FC-FE5F8E77D12F

Q34110644-5003C0F1-B584-4F6B-BC89-56436824BEC6

Q34110644-5C201BFB-FC24-4F96-BC17-31097B2A015F

Q34110644-617DC785-1ED5-480A-98F6-6F462CFEA51F

Q34110644-6B343E9A-2834-48BE-B562-4A07DE8D538B

Q34110644-81C0879F-6FCB-4E9E-93BB-49C8899E6CB4

Q34110644-838848B6-3456-45E1-9CE1-F2045BF68057

Q34110644-966D6E7B-C77A-4AF7-8CA0-B79867B6A79F

Q34110644-982F0603-4BF8-4FDC-A0B3-CC7A9AEE8660

Q34110644-A496E940-72F4-4533-A2EF-D6AEF6B6B04B

P2860

Q34110644-0B3352BF-C4F1-4629-AC60-0D808515EB6F

Q34110644-10BC0331-3492-47B8-BFB2-9121F5F7D619

Q34110644-11410F90-AB9E-4604-9896-D155AC706A01

Q34110644-13F20A40-256E-4A89-A2D5-9BC520F66C01

Q34110644-14413E5A-5FE9-43B3-B4DD-0B70E968ACA4

Q34110644-2424418E-7F7C-490B-9E77-359814CFF331

Q34110644-39400CB1-4396-4276-BCBF-D1104EF257DC

Q34110644-4316C6EC-93DB-475E-85C3-53CF39CF7C84

Q34110644-55E04B77-CCE6-4F76-BECA-C4BD8C2F7887

Q34110644-58F1793C-6035-4EF2-B445-065EABF6BAB1

P304

Q34110644-9D39BB27-44FE-416F-A33B-31A521BD34C4

P31

Q34110644-F3CE68E4-C6E5-4AA4-818D-332987A7C0A6

P356

Q34110644-FB9FB241-B1EE-4363-8EDF-3BD8596650BF

P407

Q34110644-2073F672-2EC9-4C2F-B47E-97634BE2D680

P433

Q34110644-59B97227-1564-4F70-ADD0-E851F9AB5BF9

P478

Q34110644-FFE544FD-EC53-4FDE-8C65-71DB3287D99F

P50

Q34110644-5943059B-D136-47D0-9D5E-BE85D755026F

P577

Q34110644-95AE3880-8AEE-49D7-AD98-E4A7958CB2DC

P5875

Q34110644-03CABCFF-628A-450D-9449-5CD900E4BD60

P698

Q34110644-9555898B-E3DD-4207-A1CD-8D8B3E0474E1

P932

Q34110644-81AF0745-F675-47FB-A452-3098C58B9B79

P356

JOURNAL.PONE.0029017

P1433

P1476

Disruption of TGF-β signaling ...... une keratoconjunctivitis sicca

@en

P2093

De-Quan Li

http://www.w3.org/2001/XMLSchema#string

Eugene A Volpe

http://www.w3.org/2001/XMLSchema#string

Jerry Y Niederkorn

http://www.w3.org/2001/XMLSchema#string

John D Pitcher

http://www.w3.org/2001/XMLSchema#string

Michael E Stern

http://www.w3.org/2001/XMLSchema#string

Niral B Gandhi

http://www.w3.org/2001/XMLSchema#string

Richard A Flavell

http://www.w3.org/2001/XMLSchema#string

Stephen C Pflugfelder

http://www.w3.org/2001/XMLSchema#string

William J Farley

http://www.w3.org/2001/XMLSchema#string

Xiaobo Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

Transforming growth factor-beta induces development of the T(H)17 lineage

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Transforming growth factor-beta regulation of immune responses

Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.

Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline.

Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice

Spontaneous autoimmune dacryoadenitis in aged CD25KO mice

Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.

P304

e29017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0029017

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Cintia Sade de Paiva

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51921092

http://www.w3.org/2001/XMLSchema#string

P698

22194977

http://www.w3.org/2001/XMLSchema#string

P932

3237576

http://www.w3.org/2001/XMLSchema#string